The data from this study collectively indicated that miR-195 is able to act as an inhibitor of lung adenocarcinoma by enhancing CD4+ T cell activity via the CCDC88C/Wnt signalling pathway. The gene discussed is CD4; the disease is lung adenocarcinoma.